|
HS Code |
722403 |
| Chemical Name | Isometamidium Chloride |
| Molecular Formula | C28H32ClN7O |
| Molecular Weight | 518.05 g/mol |
| Appearance | Reddish-brown powder |
| Solubility | Soluble in water |
| Use | Trypanocidal agent (treatment and prevention of animal trypanosomiasis) |
| Route Of Administration | Intramuscular injection |
| Storage Conditions | Store below 30°C, protect from light and moisture |
| Cas Number | 34301-64-3 |
As an accredited Isometamidium Chloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging consists of a sealed 50-gram amber glass bottle with a tamper-evident cap, labeled clearly with chemical details and safety information. |
| Shipping | Isometamidium Chloride should be shipped in tightly sealed, clearly labeled containers, protected from light and moisture. Follow all applicable regulations for hazardous materials, including proper documentation and safety labeling. Ensure the package is handled by trained personnel and avoid extreme temperatures. Store in a cool, dry place during transit. |
| Storage | Isometamidium Chloride should be stored in a tightly sealed container, protected from light, moisture, and heat. Keep it in a cool, dry, well-ventilated area, away from incompatible substances such as strong oxidizing agents. Store at room temperature and avoid exposure to air to prevent degradation. Ensure the storage area is secure and restrict access to authorized personnel only. |
Applications of Isometamidium Chloride in Industrial ManufacturingWe supply isometamidium chloride as an active pharmaceutical ingredient used specifically in the animal health sector for its proven trypanocidal activity. Our material has been integrated by veterinary pharmaceutical manufacturers across multiple key industrial applications where stringent regulatory oversight and process control are essential. All application scenarios described below reflect its actual, compliant, and industry-recognized uses with strictly regulated workflows and quality control requirements. 1. Injectable Trypanocide for Livestock PharmaceuticalsVeterinary pharmaceutical companies use isometamidium chloride as the major component in injectable formulations for the prophylactic and therapeutic treatment of trypanosomiasis in cattle, camels, sheep, goats, and horses. Manufacturing starts with sterile blending and dissolution of the raw material, followed by aseptic filtration and precise dosage filling under GMP conditions. The finished dosage forms play a central role in disease control strategies for ruminant livestock in endemic regions, with strict attention to API assay and pyrogen control across every manufacturing stage. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Oral Trypanocidal Premixes for Feed MillsMajor animal feed producers and premix manufacturers incorporate isometamidium chloride into oral premix additives to support the prevention of trypanosomal infections in herds susceptible to tsetse and biting-fly transmission. These feed additives require microdosing for safe delivery and uniform distribution, achieved through specialized blending and coating systems to avoid cross-contamination and API degradation during pelleting or extrusion. This application strictly follows residue monitoring requirements and batch traceability protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. In-Field Dipping and Spray Solutions for Livestock Vector ControlVeterinary product formulators manufacture potent topical solutions for livestock using isometamidium chloride, targeting trypanosome transmission by tsetse flies and other vectors. These solutions are prepared as concentrates or ready-to-dilute forms that require significant formulation stability and water compatibility. Clients require clear traceability of batch production under fully validated processes, and all finished products must pass on-site safety and environmental toxicity checks before release for use by commercial livestock operations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Reference Standards and Internal Quality Control for Veterinary Pharmaceutical FactoriesManufacturers, QC laboratories, and regulatory authorities utilize precisely characterized isometamidium chloride as a reference API standard in the development, stability testing, and release analysis of finished veterinary drugs. Reference standards must meet highest purity criteria and are often supplied with full impurity profiles, validated analytical data, and controlled documentation to ensure process standardization across multiple downstream production facilities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Isometamidium Chloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working in the chemical manufacturing industry, the relationship between raw materials, quality control, and finished products becomes personal. Isometamidium Chloride has stood out over years of experience for its unique position in veterinary applications, particularly for the control of trypanosomiasis in livestock. Producing this compound involves tight attention to detail and an understanding of both chemical synthesis and the practical requirements of field veterinarians. In our facility, we produce Isometamidium Chloride under strict environmental and batch consistency protocols. Consistent appearance, dissolution, and traceability mark every step, reflecting real-world pressures from our customers—who expect precision as a matter of course.
We produce Isometamidium Chloride as a hydrochloride salt, formulated and crystallized to meet veterinary pharmaceutical needs. Our standard offering remains the trihydrate salt for its balance of stability and solubility in practical farm applications. Batch sizes are tailored directly from aggregate demand in regions with high livestock populations suffering from tsetse-borne transmission. The synthetic pathway starts from high-purity aromatic precursors, with each intermediate purified to minimize free anilines and reduce colored byproducts. Drying and micronization steps affect the bulk density and dispersion rate, which, from repeated customer feedback, can impact how fast product dissolves at points of use.
Our laboratory performs routine HPLC and UV-Vis analysis with each lot. This recurring process picks out acetone or other potential solvents from earlier stages, a step that sets industrial manufacturing apart from small-scale or repackaged sources. We have learned that maintaining total impurity levels below 0.5 percent improves both shelf-life and field acceptability. Some manufacturers press for higher throughput by lowering purification times; in our experience, these shortcuts return as customer complaints about residues or incomplete solubility in water. It does not just affect the chemical profile—persistence of byproducts in injection sites has led to real-world problems and lost trust.
Laboratory-grade detail can only help so much if the end-user is drawing product into syringes on a hot morning in a rural village hundreds of kilometers from the nearest pharmacy. Our standard product comes as a dark red crystalline powder, packaged in airtight, light-blocking bottles to protect potency against local climate conditions. Each kilogram undergoes not only analytical testing but field simulation trials to establish time-to-dissolve at ambient and slightly elevated temperatures.
Isometamidium Chloride must resist clumping and caking under humid conditions. Through repeated engineering reviews, we adjusted the moisture range to a maximum 5 percent, accepting a minor increase in drying time for a product that arrives uniform in texture. We field a lot of questions from veterinarians working in unpredictable conditions — how it holds under poor refrigeration, or how mixing behavior changes with different water sources. Reports from users in Nigeria, Sudan, and Ethiopia drove us to improve the physical stability profile, adding steps to minimize residual solvents and coarse particles. These tweaks anchor customer relationships; veterinarians remember needing fewer filter changes and report less irritation at injection sites.
We hear firsthand how expectations for a trypanocidal agent go beyond pure chemical effect. Livestock are a family asset in many markets. A failed treatment means financial loss and hardship, so field performance matters even more than laboratory test results. Drug resistance trends present a moving target, which calls for reliability batch to batch.
Veterinarians employ Isometamidium Chloride both as a curative and preventive measure in endemic regions. Operators dissolve the powder in sterile water, filter, and deliver by intramuscular injection. Uptake by muscle tissue and sustained presence in the bloodstream depends on the fine balance of particle size and salt form. Coarse powders lead to incomplete dissolution, which in turn risks undertreatment or site abscess. Fine, consistently milled powders, like those from our current line, address these problems head-on. Over time, we standardized for a particle profile under 100 microns — direct feedback from vets improved our specifications, reducing complaints about persistent lumps or cloudy suspensions.
Field veterinarians and agri-cooperatives weigh Isometamidium Chloride against other products such as diminazene aceturate, suramin, and homidium salts. Each has its specific profile for action, duration, injection site reactions, and practicality under field conditions. Our decades in the sector reveal that Isometamidium Chloride stands out for longer duration in the bloodstream, offering extended protection and allowing less frequent interventions at the herd level. This characteristic emerges from its unique chemical backbone and slow metabolic clearance.
Some alternative drugs work faster but require frequent re-injection, which strains resources and increases animal stress. Socioeconomic studies from West African pastoral zones underscore the value of sustainability — less handling lowers the risk of injury and loss. We share case studies and field data, not only chemical specifications, because trust builds over time. Our product’s slower release aligns with the seasonal movement of herds, and customers recount improved herd retention and fewer cases per head. Ongoing lab investment brings continual adjustment in particle size, clarity of solution, and reduction of injection reactions—areas where earlier generations of our own product trailed the competition.
Quality from a manufacturer is more than paperwork or passing batch records; it’s an unbroken chain from raw material sourcing, through reaction vessels, to the hands of a veterinarian in a distant town. Customers often call directly to ask why one batch dissolves more quickly than another, or how stability in tropic climates compares after six months. We take time to explain how the trihydrate form resists breakdown even above 30 degrees Celsius, based on trials stored in warehouse-like conditions with high ambient moisture. These insights come not from tables but from side-by-side tests and dealing with problems after distribution.
We see first-hand the effects of inconsistent quality — crystallization in vials under field conditions, filter clogging, and even allergic reactions in treated animals. Our technical staff includes long-term veterinary partners who run field lots alongside routine batches, sending samples for analysis if any problem arises. These collaborations improve our process more than any ISO document or third-party audit.
Global supply conditions shift with political and economic trends. Raw material shortages, transport delays, and sudden changes in regulatory requirements all affect the pace and consistency of production. Over the past decade, we found that keeping excess stock of precursor chemicals pays off in fewer missed production runs. Attention to full traceability — from the origin of dyes used in synthesis to the third-party energy audits — not only builds import approval but also gives buyers confidence when customs reviews each batch at the border.
Each market presents separate challenges. Some require batch-specific certificates of analysis signed by the chief chemist. Others demand residue studies showing sub-ppm impurity profiles in farm conditions. Our regulatory team prepares these not only to meet compliance but also to help buyers avoid shipment refusal or destroyed consignment—a lesson learned from hard experience in the past. Each incident where ships were forced to return cargo prompted process reviews and genuine innovations in our product stabilization. For instance, after repeated shipment rejections due to minor color differences, we upgraded to spectrophotometric lot comparison alongside basic chromatography data.
Experience tells us that continuous improvement does not grow in a vacuum. Real-world feedback forms the backbone of our manufacturing changes. Some years ago, customers in East Africa reported higher rates of recrystallization during the rainy season. Our initial reaction was to review our standard drying protocol, but site visits told a different story — water sources used to dilute for injection had higher mineral content, which interacted with the chloride salt in unexpected ways. This information prompted a shift toward a broader buffer range, ensuring stable reconstitution under a wider set of local conditions. We trialed changes alongside our partners and saw measurable improvements in field reports within months.
Collaborations with university research teams drive updates to our testing methods. A recent joint project with veterinary pharmacologists introduced sharper dissolution tests that revealed microimpurities missed by basic spot tests. We implemented additional filtration steps and started publishing summary lab results, fostering trust among key buyers who value open process data as much as final results.
Protecting the stability and ease of use of Isometamidium Chloride demands careful packaging choices. We select multilayer, light-resistant plastics that prevent both moisture ingress and UV degradation through extended storage in unregulated environments. Repeated trials with different closure types—flip-cap, screw-thread, heat seal—told us which options hold up through rough transport and daily use without contaminating the contents or introducing plasticizers.
Clear, well-adhered labeling stands out as an essential step rather than a sales tool. Emergency response information, preparation instructions, and batch numbers rest directly on each unit, not just the secondary shipping carton. These choices come from hard-earned lessons in regions where a single missing mark turns a good batch into an unusable one.
Recent upgrades to our tamper-evidence strip shortened the shelf setup time in veterinary clinics and reduced the risk of inadvertent dilution or early opening. Isometamidium Chloride has a characteristic deep red color, and environmental exposure, even for a few hours, can degrade active content, which becomes immediately obvious to trained users in the field. We reinforce this protection with clearly visible expiry coding and QR-linked lot traceability, ensuring every product shipped can be tracked back to the day of final packing.
Operating in this sector, we see the impact our plant has on the surrounding community and natural resources. Byproducts from the Isometamidium Chloride process require careful management, with on-site treatment tanks reducing the discharge load well below local regulatory limits. Our water recycling program recoups spent solvent for other cycle uses, minimizing total environmental footprint.
Neighboring farms and water sources benefit from these practices. We maintain open channels with local authorities and civil society groups, not because rules require it, but because public trust sustains operations through unpredictable regulatory cycles. We hold regular open days for local schools, giving the next generation a firsthand look at both the risks and benefits of pharmaceutical manufacturing.
Trypanosomiasis continues to challenge livestock economies across several continents, and Isometamidium Chloride remains a keystone tool in both prevention and treatment. As resistance profiles evolve, demand for reliable, high-quality drug supply mounts. Anticipating future needs calls for not just more product, but product that adapts to emerging veterinary guidance and diagnostic technology.
We have invested in research partnerships to examine lower-dose regimens and accompanying diagnostic kits, ensuring our manufacturing shifts align with on-farm realities rather than just regulatory updates. Efforts to integrate rapid testing and tracking software mean our production schedule becomes more responsive to real outbreaks, not just annual forecasts. By maintaining flexibility in lot sizing and packaging, we support not only large agricultural enterprises but also smallholder farmers, often hit hardest by disease.
Years in direct manufacturing teach that buyers want more than a container of red powder — they want all the embedded reliability, insight, and commitment behind it. We distribute field guides, troubleshooting checklists, and practical mixing instructions as part of every order. The goal is not just delivering a reagent but supporting the veterinarians and farmers who depend on it daily.
Our ongoing dialog with end users guides both our short-term modifications and our long-term investments. When a veterinary service group in Senegal reported minor batch differences in solution clarity, we visited, observed their mixing procedure, and introduced minor tweaks in our grain size, which resolved the issue. These experiences cement relationships and distinguish our products from large-batch, trader-oriented versions that often ignore field realities.
The challenge for a manufacturer is keeping one step ahead of shifts in disease resistance and field requirements. We monitor international research trends and host feedback workshops with regional veterinary extension services. Our R&D team explores salt variants and encapsulation methods to address emerging concerns around injection site pain and residue limits. Early studies hint that co-formulated buffers can further reduce tissue irritation, and new packaging systems cut down accessibility barriers for practitioners working alone or in low-resource settings.
We renew our commitment to transparency by providing access to analytical profiles and publishing summaries of ongoing stability studies on our internal site. We work closely with importing authorities to clear up confusion from batch delays, regulatory change, or customer mix-ups. All these efforts grow out of practical reality — setbacks and solutions that can only come from hands-on experience in manufacturing.
Every kilogram of Isometamidium Chloride that leaves our facility carries more than its chemical identity. It represents the skills of our process technicians, the experience of working veterinarians, and the day-to-day reality of livestock keepers striving to protect their herds. Our greatest satisfaction comes from seeing our product arrive intact, perform as intended, and contribute to healthier animals and more stable rural economies.
Direct involvement, unfiltered feedback, and continual adaptation define our approach. For us, Isometamidium Chloride is not just another commodity chemical—it is a lifeline for agricultural communities and a daily test of manufacturing integrity.